OQROGet OQRO Pro
Insider trade

Elevance Health (ELV)Director bought ~$375K

Susan D. Devore, Director at Elevance Health, bought ~$375K of Elevance Health shares.

~$375K
Approx. value · 1,200 sh @ $312.15
3,502
Holds after · shares reported
Traded
Aug 19, 2025
Filed
Aug 21, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 29, 2024CongressDisclosed purchase of ELV — reported range $1,001 - $15,000
  2. Jan 13, 2025CongressDisclosed sale of ELV — reported range $1,001 - $15,000
  3. May 12, 2025CongressDisclosed sale of ELV — reported range $15,001 - $50,000
  4. Jun 24, 2025CongressDisclosed purchase of ELV — reported range $1,001 - $15,000
  5. Jul 10, 2025Congress · 1 personMembers of Congress: 2 purchases
  6. Jul 18, 2025Insider · 1 personInsiders: 3 purchases (~$2.4M)
  7. Aug 5, 2025CongressDisclosed purchase of ELV — reported range $1,001 - $15,000
  8. Aug 13, 2025CongressDisclosed sale of ELV — reported range $1,001 - $15,000
  9. Aug 19, 2025 · this disclosureInsiderDirector purchased ~$375K of ELV shares in the open market

What came next

  1. Oct 21, 2025Company filing · Form 8-K · ResultsReported its results
  2. Dec 10, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 10, 2025, the Board of Directors (the “Board”) of Elevance Health, Inc. (the “Company”) elected Amy W. Schulman to serve as an independent director effective January 12, 2026, with a term expiring at the Company’s 2028 annual meeting of shareholders.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Elevance Health

For Elevance Health, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 37 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ELV page.

Other recent filings by Susan D. Devore, Director

The full history of Susan D. Devore, Director is on the profile page.

How this filing works

Other disclosures at Elevance Health

Everything OQRO holds on this company is on its ELV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data